Results 51 to 60 of about 20,292 (247)

When Fat Goes Astray: Your Liver and Pancreas Get Into Trouble

Portal Hypertension &Cirrhosis, EarlyView.
Metabolic dysfunction‐associated steatotic liver disease (MASLD) and intrapancreatic fat deposition (IPFD) are both common manifestations of ectopic fat accumulation. Although they share multiple risk factors, they also show notable differences in pathological features, standardization of diagnosis, and research maturity.
Yuying Chen, Li Ding, Shan Zhao, Weihong Wang, Jing Zhong, Qiang Yan   +5 more
wiley   +1 more source

The 2018 cholesterol management guidelines: Topics in secondary ASCVD prevention clinicians need to know

, 2019
Purpose of review: The 2018 ACC/AHA Multisociety blood cholesterol guidelines provide updated recommendations based on contemporary evidence on the management of serum cholesterol for the prevention of atherosclerotic cardiovascular disease (ASCVD ...
Virani, Salim S., Smith, Sidney C, Jr, Jia, Xiaoming, Al Rifa, Mahmoud, Birnbaum, Yochai   +4 more
core   +2 more sources

Datasets and Variable Definitions for Cytochrome P450 Derived Eicosanoids and ASCVD

, 2021
This project is comprised of two distinct research cohorts of patients with clinically established atherosclerotic cardiovascular disease (ASCVD), defined as a prior revascularization procedure or current ≥ 50% coronary artery stenosis in a major ...
Lee, Craig
core   +1 more source

Cost‐effectiveness of in‐hospital motivational smoking cessation counselling and proactive referral to community‐based follow‐up

Addiction, EarlyView.
Abstract Background and aim In a randomised open‐label trial among hospitalised patients with atherosclerotic vascular disease, motivational smoking cessation counselling with proactive referral to community‐based follow‐up was more effective than brief cessation advice and written information, with 6‐month continuous abstinence rates of 49.5% vs. 24.5%
Karin Pleym, Ingrid Engebretsen, Elise Sverre, Toril Dammen, Einar Huseby, Mohpal Singh Kahlon, Marie Stugaard, Henrik Støvring, Ivar Sønbø Kristiansen, John Munkhaugen   +9 more
wiley   +1 more source

Educating Providers regarding the ASCVD Risk Calculator in a Primary Care Setting: A Quality Improvement Program

, 2021
Background: Atherosclerotic cardiovascular disease (ASCVD) is a production of plaque buildup in the arterial walls that can lead to a myocardial infarction (MI) or cerebrovascular accident (CVA).
Armstrong, Shanice Antoinett
core  

Impact of incretin analogues on lipid and lipoprotein metabolism in obesity and diabetes

British Journal of Pharmacology, EarlyView.
Abstract Incretin‐based therapies have gained momentum as a key strategy for reducing cardiovascular risk in individuals with obesity and/or type 2 diabetes (T2D). It remains unclear whether the cardiovascular benefits reflect a direct reduction in atherogenic lipoproteins—namely, low‐density lipoproteins (LDL), very low‐density lipoproteins (VLDL) and
Andrea Baragetti, Giuseppe Danilo Norata
wiley   +1 more source

Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus

Renal Failure, 2021
Aims Chronic kidney disease (CKD) and diabetes mellitus increase atherosclerotic cardiovascular diseases (ASCVD) risk. However, the association between renal outcome of diabetic kidney disease (DKD) and ASCVD risk is unclear.
Honghong Ren, Lijun Zhao, Yutong Zou, Yiting Wang, Junlin Zhang, Yucheng Wu, Rui Zhang, Tingli Wang, Jiali Wang, Yitao Zhu, Ruikun Guo, Huan Xu, Lin Li, Mark E. Cooper, Fang Liu   +14 more
doaj   +1 more source

THE EFFECTS OF WEIGHT LOSS AND AEROBIC EXERCISE ON 10-YEAR AND LIFETIME ASCVD RISK

, 2023
Tyler Brown1, Emily Grammer2, Taylor Brown1, Josh McGee1, Marie Clunan1, Anna Huff1, Briceida Osborne1, Laura Matarese1, Walter Pories1, Joseph Houmard1, Robert Carels1, Damon Swift2. 1East Carolina University, Greenville, NC.
Pories, W, Huff, A, Clunan, M, Osborne, B, Matarese, L, Brown, T, Carels, R, Grammer, E, Swift, D, McGee, J, Houmard, J   +10 more
core  

GIP in Cardiovascular and Kidney Disease: From Physiology to Pharmacology

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To provide a comprehensive overview of the cardiovascular and renal effects of glucose‐dependent insulinotropic polypeptide (GIP) by integrating its physiological role with recent human trial data on tirzepatide, the first dual GIP and glucagon‐like peptide‐1 (GLP‐1) receptor agonist.
Michelantonio De Fano, Line L. Haurum, Christine R. Schwarz, Francesca Porcellati, Andreas Andersen   +4 more
wiley   +1 more source

THE EFFECTS OF WEIGHT LOSS AND AEROBIC EXERCISE ON 10-YEAR AND LIFETIME ASCVD RISK CALCULATED USING THE POOLED COHORT EQUATIONS

, 2023
BACKGROUND: Atherosclerotic Cardiovascular Disease (ASCVD) is the leading cause of morbidity and mortality in the United States. The American Heart Association (AHA) and American College of Cardiology (ACC) developed the Pooled Cohort Equations (PCE) to ...
NC DOCKS at East Carolina University, Brown, Tyler Desean   +1 more
core